HI
PHXM

Harbour Investments’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Harbour Investments’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$6K – 3842
2021
Q3 		$6K Buy
+100
New +$5.6K ﹤0.01% 2941

Other funds holding PHXM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Harbour Investments's PHXM Position: Q4 2021 in Review

Harbour Investments sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2021, closing a stake of 100 shares — an estimated $6K sold.

Harbour Investments first reported a position in PHXM in Q3 2021 and held it in 1 quarter. The position peaked at $6K in Q3 2021. 9 funds tracked by Wall St. Rank hold PHXM as of Q4 2021.

  • Harbour Investments reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 100 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2021, an estimated $6K.
  • Harbour Investments first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q3 2021 and held it in 1 quarter.
  • Harbour Investments's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $6K in Q3 2021.
  • 9 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.